Combined Intake of Caffeine and Low-Dose Glucose to Reduce Exercise-Related Hypoglycaemia in Individuals With Type 1 Diabetes on Ultra–Long-Acting Insulin Degludec
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial
Diabetes Obes Metab 2024 Apr 01;[EPub Ahead of Print], T Kühne, E Wallace, D Herzig, S Helleputte, S Scott, J Pickles, A Melmer, C StettlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.